Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devashish Desai

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Cureus|February 12, 2024
Obstructive Sleep Apnea: A Contributing Factor in GoutPushti Khandwala, Devashish Desai, Mitali Sen
ACR Open Rheumatology|January 24, 2025
Prevalence of Autoimmune Diseases in Patients Treated With Immune Checkpoint Inhibitors: An Epidemiological Study Using A Global Network of Health Care OrganizationsPushti Khandwala, Devashish Desai, Arthur Lau
Cureus|May 13, 2022
Evaluating the Correlation of Bariatric Surgery and the Prevalence of Cancers in Obese Patients: A Study of the National Inpatient Sample (NIS) DatabaseDevashish Desai, Sachi Singhal, Jean Koka
Virusdisease|May 10, 2021
High prevalence of plasma EBV DNA among the HIV positive individuals, with or without malignancies, attending the clinic at AIIMS, New DelhiDibyakanti Mandal, Devashish Desai, Sanjeev Sinha
The Lancet. Infectious Diseases|May 26, 2020
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approachPraveen Tilangi, Devashish Desai, Adil Khan, et al.
Medical Oncology (Northwood, London, England)|April 23, 2021
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancerDevashish Desai, Pushti Khandwala, Meghana Parsi, et al.
BMJ Case Reports|August 14, 2018
Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritisDevashish Desai, Kartik Gupta, Rohit Kumar, et al.
The Indian Journal of Medical Research|August 11, 2020
False reassurance or inadequate drug levels?Praveen Tirlangi, Adil Rashid Khan, Devashish Desai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Cureus|February 12, 2024
Obstructive Sleep Apnea: A Contributing Factor in GoutPushti Khandwala, Devashish Desai, Mitali Sen
ACR Open Rheumatology|January 24, 2025
Prevalence of Autoimmune Diseases in Patients Treated With Immune Checkpoint Inhibitors: An Epidemiological Study Using A Global Network of Health Care OrganizationsPushti Khandwala, Devashish Desai, Arthur Lau
Cureus|May 13, 2022
Evaluating the Correlation of Bariatric Surgery and the Prevalence of Cancers in Obese Patients: A Study of the National Inpatient Sample (NIS) DatabaseDevashish Desai, Sachi Singhal, Jean Koka
Virusdisease|May 10, 2021
High prevalence of plasma EBV DNA among the HIV positive individuals, with or without malignancies, attending the clinic at AIIMS, New DelhiDibyakanti Mandal, Devashish Desai, Sanjeev Sinha
The Lancet. Infectious Diseases|May 26, 2020
Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approachPraveen Tilangi, Devashish Desai, Adil Khan, et al.
Medical Oncology (Northwood, London, England)|April 23, 2021
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancerDevashish Desai, Pushti Khandwala, Meghana Parsi, et al.
BMJ Case Reports|August 14, 2018
Levosulpiride-induced neuroleptic malignant syndrome in rheumatoid arthritisDevashish Desai, Kartik Gupta, Rohit Kumar, et al.
The Indian Journal of Medical Research|August 11, 2020
False reassurance or inadequate drug levels?Praveen Tirlangi, Adil Rashid Khan, Devashish Desai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 30, 2026
CLO26-075: Are PARP Inhibitors Effective Beyond Homologous Recombination Repair-Deficiency in Castration-Resistant Prostate Cancer? A Meta-AnalysisSusu Zhou, Devashish Desai, Sam Benjamin, et al.
Pageof 4